CD274 and neoplasm: Our results also strongly correlate with recent literature demonstrating that blocking the PD-1/PD-L1 axis with an anti-PD-1 antibody leads to a substantial reduction in tumor growth of MC38 or CT26 tumor bearing mice [59–61].